Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-10-30
|
pubmed:abstractText |
We have examined the possible role of transforming growth factor-beta (TGF-beta) in metastatic malignancy by analyzing the production and activation of TGF-beta 1 and -beta 2 and the regulation of TGF-beta-responsive genes in oncogene-transformed metastatic fibrosarcomas. All transformed lines derived from either 10T1/2 or NIH 3T3 by either H-ras or protein-kinase encoding oncogenes produced more TGF-beta than parental cells. However, only highly metastatic fibrosarcomas secreted activated TGF-beta at rates that were greater than parental fibroblasts. Immunohistochemical staining for TGF-beta 1 showed widespread intra- and extracellular distribution in metastatic lung nodules and adjacent tissue. Cells isolated from tumors successfully metastasizing to the lung had TGF-beta 1 mRNA levels which were increased 19-fold over in vitro controls. Despite the greatly enhanced rate of secretion of activated TGF-beta, metastatic cells exhibited markedly altered responses of TGF-beta 1 and TGF-beta 2, being unable to either increase collagen secretion or enhance collagen alpha 2(1) or TGF-beta 1 mRNA levels. This lack of response was not due to either altered TGF-beta receptor affinity or numbers. Metastatic progression was, therefore, associated with an increase in the secretion of activated TGF-beta 1 and a loss of the ability to deregulate TGF-beta-responsive genes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0897-7194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-27
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:2169772-Animals,
pubmed-meshheading:2169772-Cell Line, Transformed,
pubmed-meshheading:2169772-Fibrosarcoma,
pubmed-meshheading:2169772-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:2169772-Immunohistochemistry,
pubmed-meshheading:2169772-Lung Neoplasms,
pubmed-meshheading:2169772-Mice,
pubmed-meshheading:2169772-Mice, Inbred C3H,
pubmed-meshheading:2169772-Oncogenes,
pubmed-meshheading:2169772-Protein Kinases,
pubmed-meshheading:2169772-RNA, Messenger,
pubmed-meshheading:2169772-Receptors, Cell Surface,
pubmed-meshheading:2169772-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:2169772-Transforming Growth Factor beta,
pubmed-meshheading:2169772-Tumor Cells, Cultured
|
pubmed:year |
1990
|
pubmed:articleTitle |
Aberrant TGF-beta production and regulation in metastatic malignancy.
|
pubmed:affiliation |
Manitoba Institute of Cell Biology, Winnipeg, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|